Antibodies to Pre‐erythrocyticPlasmodium falciparumAntigens and Risk of Clinical Malaria in Kenyan Children
Open Access
- 15 February 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (4), 519-526
- https://doi.org/10.1086/526787
Abstract
Background. IgG antibodies to pre-erythrocytic antigens are involved in prevention of infection and disease in animal models of malaria but have not been associated with protection against disease in human malaria. Methods. Levels of IgG antibodies to circumsporozoite protein (CSP), liver-stage antigen type 1 (LSA-1), and thrombospondin-related adhesive protein (TRAP) were measured in 86 children in a malaria-holoendemic area of Kenya. The children were then monitored for episodes of clinical malaria for 52 weeks. Results. Children with high levels of IgG antibodies to CSP, LSA-1, and TRAP had a decreased risk of clinical malaria (adjusted hazard ratio, 0.29; 95% confidence interval 0.10–0.81; P = .02), a lower incidence of clinical malaria (P = .006), protection from clinical malaria with a parasite level of ⩾4000 parasites/µL (P = .03), and a higher hemoglobin level at enrollment (P = .009), compared with children with lower antibody levels. Protection against malaria morbidity was associated primarily with antibodies to CSP and LSA-1. Conclusions. Kenyan children with high levels of IgG antibodies to the pre-erythrocytic antigens CSP, LSA-1, and TRAP have a lower risk of developing clinical malaria than children without high levels of these antibodies. The decreased risk of clinical malaria may be mediated in part by prevention of high-density parasitemia.Keywords
This publication has 48 references indexed in Scilit:
- Human Recombinant Antibodies againstPlasmodium falciparumMerozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic PropertiesInfection and Immunity, 2006
- Gamma Interferon Responses toPlasmodium falciparumLiver-Stage Antigen 1 and Thrombospondin-Related Adhesive Protein and Their Relationship to Age, Transmission Intensity, and Protection against MalariaInfection and Immunity, 2004
- Antibodies to thePlasmodium falciparumAntigens Circumsporozoite Protein, Thrombospondin-Related Adhesive Protein, and Liver-Stage Antigen 1 Vary by Ages of Subjects and by Season in a Highland Area of KenyaInfection and Immunity, 2003
- Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersVaccine, 2003
- Cytokine Responses toPlasmodium falciparumLiver-Stage Antigen 1 Vary in Rainy and Dry Seasons in Highland KenyaInfection and Immunity, 2000
- Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation ratesParasite Immunology, 1999
- Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes.The Journal of Experimental Medicine, 1993
- γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesNature, 1987
- Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide.The Journal of Experimental Medicine, 1984
- Gamma-Globulin and Acquired Immunity to Human MalariaNature, 1961